Hydrochloric Acid

Hydrochloric Acid

SCHEMBL4731344

Cl.Nc1ccc(Oc2ncnc3ccccc23)cc1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR known ✓ P00533 2/20 0.56
CSF1R known ✓ P07333 1/20 0.53
KDR known ✓ P35968 3/20 0.49
PDGFRB known ✓ P09619 1/20 0.48
KIT known ✓ P10721 1/20 0.48
FLT1 known ✓ P17948 1/20 0.48
FLT4 known ✓ P35916 1/20 0.48
MAPK14 known ✓ Q16539 1/20 0.46
KDM1A O60341 1/20 0.53
RAB9A P51151 3/20 0.50
NPC1 O15118 2/20 0.50
TSHR P16473 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
TEK Q02763 1/20 0.49
PI4KA P42356 1/20 0.49
PI4K2B Q8TCG2 1/20 0.49
PI4K2A Q9BTU6 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8200916 0.98 EGFR (0.57) EGFRCSF1RKDM1ARAB9ANPC1
SCHEMBL3979754 0.84 EGFR (0.69) EGFRCSF1RRAB9ANPC1TSHR
SCHEMBL3977060 0.82 EGFR (0.57) EGFRRAB9ANPC1TSHRL3MBTL1
SCHEMBL3106181 0.82 EGFR (0.57) EGFRCSF1RRAB9ANPC1TSHR
SCHEMBL3635988 0.80 EGFR (0.62) EGFRRAB9ANPC1TSHRL3MBTL1
SCHEMBL11286630 0.79 RAB9A (0.56) EGFRCSF1RRAB9ANPC1TSHR
SCHEMBL3980790 0.78 EGFR (0.54) EGFRCSF1RRAB9ANPC1TSHR
SCHEMBL4078517 0.78 KDR (0.61) EGFRCSF1RRAB9ANPC1TSHR
SCHEMBL17508505 0.78 EGFR (0.54) EGFRCSF1RRAB9ANPC1TSHR
SCHEMBL22533772 0.77 CSF1R (0.53) EGFRCSF1RKDRRAF1PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200392110-A1 QUINOLINE DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2020-12-17 US disclosed
EP-3415501-B9 QUINOLINE DERIVATIVE ONO PHARMACEUTICAL CO (JP) 2020-12-02 EP disclosed
US-10676462-B2 Quinoline derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2020-06-09 US disclosed
EP-3415501-B1 QUINOLINE DERIVATIVE ONO PHARMACEUTICAL CO (JP) 2020-04-08 EP disclosed
US-10501442-B2 Quinoline derivative ONO PHARMACEUTICALS CO., LTD. (JP) 2019-12-10 US disclosed
US-20190135785-A1 QUINOLINE DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2019-05-09 US disclosed
US-10208022-B2 Quinoline derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2019-02-19 US disclosed
EP-3415501-A1 QUINOLINE DERIVATIVE ONO Pharmaceutical Co., Ltd. (JP) 2018-12-19 EP disclosed
US-20180258072-A1 QUINOLINE DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2018-09-13 US disclosed
US-9994549-B2 Quinoline derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2018-06-12 US disclosed
US-20170088542-A1 QUINOLINE DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2017-03-30 US disclosed
US-9573935-B2 Quinoline derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2017-02-21 US disclosed
US-20160168121-A1 QUINOLINE DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2016-06-16 US disclosed
EP-3026045-A1 QUINOLINE DERIVATIVE ONO Pharmaceutical Co., Ltd. (JP) 2016-06-01 EP disclosed
WO-2008042867-A2 MODULATORS OF MULTIPLE KINASES EMILIEM INC. (US) 2008-04-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200392110-A1 QUINOLINE DERIVATIVE FLT3, AXL, ERBB2 EGFR 17/4885CSF1R 33/4885KDR 27/4885
US-10501442-B2 Quinoline derivative FLT3, AXL, ERBB2 EGFR 17/4885CSF1R 33/4885KDR 27/4885
US-20180258072-A1 QUINOLINE DERIVATIVE FLT3, AXL, ERBB2 EGFR 17/4885CSF1R 33/4885KDR 27/4885
US-10208022-B2 Quinoline derivative FLT3, AXL, ERBB2 EGFR 17/4885CSF1R 33/4885KDR 27/4885
US-20160168121-A1 QUINOLINE DERIVATIVE FLT3, AXL, ERBB2 EGFR 24/4885CSF1R 40/4885KDR 65/4885
US-20170088542-A1 QUINOLINE DERIVATIVE FLT3, AXL, ERBB2 EGFR 17/4885CSF1R 33/4885KDR 27/4885
US-10676462-B2 Quinoline derivative FLT3, AXL, ERBB2 EGFR 17/4885CSF1R 33/4885KDR 27/4885
US-20190135785-A1 QUINOLINE DERIVATIVE FLT3, AXL, ERBB2 EGFR 17/4885CSF1R 33/4885KDR 27/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.